"Sheryl is an excellent addition to our team as we begin to build out our health care effort," said Kevin Fisher, President and Co-head of Equities at Pali Capital. "Her industry knowledge, proven track record and ability to make strong and actionable research calls across the capital structure will serve our clients well."
Dr. Skolnick added, "I appreciate what the Pali research effort stands for, a commitment to providing clients with unfettered and actionable analysis. I look forward to helping expand the firm's research platform and helping to grow this already strong franchise."
During her career on Wall Street, Dr. Skolnick has worked at various buy-side and sell-side research firms including Robertson Stephens, Fulcrum Global Partners and CRT Capital Group. Dr. Skolnick is an Adjunct Lecturer at Columbia University's Executive Masters in Public Health program. She has a Ph.D. in Economics from Washington University in St. Louis where she was an Olin Fellow. A noted speaker at industry and academic conferences, Dr. Skolnick is often called on to provide expert commentary regarding health care issues.
About Pali Capital
Pali Capital, Inc., is the U.S.-based division of Pali Holdings, Inc., an independent, global financial services firm and investment bank servicing institutional clients since 1995. Pali offers equity, fixed income, and derivatives sales and trading, equity research, structured finance, and corporate finance and advisory services. The firm maintains primary offices in New York and London, with additional offices in San Francisco, Newport Beach, Chicago, Boca Raton, Minneapolis, Boston and Summit, NJ. Please visit www.pali.com for additional information.
SOURCE: Pali Capital, Inc.
Pali Capital, Inc. Russell Sherman, 212-259-5120

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index